Related Experiment Videos
Developmental changes of adenocarcinoma-associated antigen
K Kithier1, M P Whitcomb, M L Benner
1Department of Pathology, Wayne State University School of Medicine, Detroit, Mich. 48201.
Fetal Diagnosis and Therapy
|January 1, 1994
Summary
Adenocarcinoma-associated antigen (ACAA) shows higher serum concentrations in fetuses, newborns, and mothers compared to healthy adults. This suggests ACAA has fetospecific characteristics, functioning as a normal human serum protein, not just a tumor marker.
Area of Science:
- Biochemistry
- Immunology
- Oncology
Background:
- Adenocarcinoma-associated antigen (ACAA) is a protein of interest in cancer research.
- Oncofetal proteins are typically expressed during fetal development and re-expressed in certain cancers.
Purpose of the Study:
- To investigate the occurrence and serum concentrations of ACAA during the fetal period, in newborns, and in their mothers.
- To determine if ACAA exhibits fetospecific characteristics.
Main Methods:
- Serum samples were collected from fetuses, newborns, and their mothers.
- Serum concentrations of ACAA were measured and compared to healthy, nonpregnant adults.
Main Results:
- Mean ACAA concentrations were significantly elevated in fetal, newborn, and maternal sera compared to healthy adults.
- These findings indicate a distinct pattern of ACAA expression during pregnancy and early life.
Conclusions:
- ACAA demonstrates fetospecific features, similar to other known oncofetal proteins.
- ACAA should be considered a normal protein constituent of human serum in addition to its potential role as a tumor marker.